← Back to Search

SKED© for Patient Packaging and Transport Methods

N/A

Waitlist Available

Led By Christopher Davis, MD

Research Sponsored by Wake Forest University Health Sciences

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up minute 5

Awards & highlights

Study Summary

This trial is testing different ways of strapping patients onto a SKED stretcher to see if it affects their respiratory system or how comfortable they are.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ minute 5

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~minute 5

This trial's timeline: 3 weeks for screening, Varies for treatment, and minute 5 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Borg Dyspnea scale

Change in End-Tidal Carbon Dioxide (ETCO2)

Change in Heart Rate

+6 more

Trial Design

4Treatment groups

Experimental Treatment

Group I: Arm1: SKED© only firstExperimental Treatment1 Intervention

Each participant will be packaged using a SKED© system with no assumed spinal injury. Each arm will consist of the same interventions in a specified, but unique order. Arm 1 will be in the following order: SKED© only; SKED©+OSS-II©; SKED©+Vacuum mattress; SKED©+foam padding

Group II: Arm 4: SKED©+foam padding firstExperimental Treatment1 Intervention

Each participant will be packaged using a SKED© system with no assumed spinal injury. Each arm will consist of the same interventions in a specified, but unique order. Arm 4 will be in the following order: SKED©+foam padding, SKED©+Vacuum mattress; SKED© only; SKED©+OSS-II

Group III: Arm 3: SKED©+OSS-II© firstExperimental Treatment1 Intervention

Each participant will be packaged using a SKED© system with no assumed spinal injury. Each arm will consist of the same interventions in a specified, but unique order. Arm 3 will be in the following order: SKED©+OSS-II©;SKED©+Vacuum mattress; SKED© only; SKED©+foam padding

Group IV: Arm 2: SKED©+Vacuum mattress firstExperimental Treatment1 Intervention

Each participant will be packaged using a SKED© system with no assumed spinal injury. Each arm will consist of the same interventions in a specified, but unique order. Arm 2 will be in the following order: SKED©+Vacuum mattress; SKED©+OSS-II©; SKED©+foam padding, SKED© only

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor

1,240 Previous Clinical Trials

1,004,207 Total Patients Enrolled

Christopher Davis, MDPrincipal InvestigatorWake Forest University Health Sciences

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I meet the criteria to be eligible for enrollment in this clinical trial?

"The criteria for entry into this clinical trial necessitates that applicants be within the age range of 18 and 65, as well as compare patient packaging and transport methods. Currently, there is a need to recruit approximately 50 individuals."

Answered by AI

Is it still possible to join this experiment?

"Per clinicaltrials.gov, the recruitment period for this medical trial has concluded; it was initially posted on January 1st 2023 and had a final edit date of September 13th 2022. However, there is another ongoing study that currently accepts new candidates."

Answered by AI